Issued Patents All Time
Showing 1–16 of 16 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12384847 | Cancer therapy involving an anti-PD1 antibody and a multi-specific binding protein that binds NKG2D, CD16, and a tumor-associated antigen | Gregory P. Chang, Ann F. Cheung, Asya Grinberg, Eva Gutierrez, William Haney +2 more | 2025-08-12 |
| 12384851 | Multi-specific binding proteins that bind BCMA, NKG2D and CD16, and methods of use | Mitchell Bigelow, Gregory P. Chang, Ann F. Cheung, Asya Grinberg, William Haney +5 more | 2025-08-12 |
| 12275791 | Multi-specific binding proteins that bind HER2, NKG2D, and CD16, and methods of use | Gregory P. Chang, Ann F. Cheung, Daniel Fallon, Asya Grinberg, William Haney +4 more | 2025-04-15 |
| 12037392 | Treatment regimens using anti-NKG2A antibodies | Pascale Andre, Mathieu Blery, Carine Paturel, CAROLINE SOULAS | 2024-07-16 |
| 11787864 | Heterodimeric Fc-fused proteins | Ann F. Cheung, Jean-Marie Cuillerot, Asya Grinberg, Eva Gutierrez, William Haney | 2023-10-17 |
| 11623954 | Siglec-9-neutralizing antibodies | STÉPHANIE CORNEN, Benjamin Rossi, Laurent Gauthier | 2023-04-11 |
| 11572410 | Neutralization of inhibitory pathways in lymphocytes | Pascale Andre, Mathieu Blery, Carine Paturel | 2023-02-07 |
| 11447545 | Combination therapy using antibody to human Siglec-9 and antibody to human NKG2A for treating cancer | STÉPHANIE CORNEN, Benjamin Rossi | 2022-09-20 |
| 11225519 | Treatment of cancers using anti-NKG2A agents | Pascale Andre, Mathieu Blery, CAROLINE SOULAS | 2022-01-18 |
| 11083785 | Siglec-10 antibodies | STÉPHANIE CORNEN, Laurent Gauthier, Benjamin Rossi | 2021-08-10 |
| 11078274 | Siglec neutralizing antibodies | STÉPHANIE CORNEN, Benjamin Rossi | 2021-08-03 |
| 10870700 | Neutralization of inhibitory pathways in lymphocytes | Pascale Andre, Mathieu Blery, CAROLINE DENIS, Carine Paturel | 2020-12-22 |
| 10711063 | Neutralization of inhibitory pathways in lymphocytes | Pascale Andre, Mathieu Blery, Carine Paturel | 2020-07-14 |
| 10676523 | Treatment regimens using anti-NKG2A antibodies | Pascale Andre, Mathieu Blery, Carine Paturel, CAROLINE SOULAS | 2020-06-09 |
| 10329348 | Treatment of cancers using anti-NKG2A agents | Pascale Andre, Mathieu Blery, CAROLINE SOULAS | 2019-06-25 |
| 5808028 | Molecular clone of a P58 receptor protein and uses thereof | Eric O. Long | 1998-09-15 |